• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Andra medicinska specialiteter
    3. Farmakologi

    Drug Discovery

    Practices, Processes, and Perspectives

    AvJie Jack Li,E. J. Corey

    Inbunden, Engelska, 2013

    1 532 kr

    Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Sets forth the history, state of the science, and future directions of drug discoveryEdited by Jie Jack Li and Nobel laureate E. J. Corey, two leading pioneers in drug discovery and medicinal chemistry, this book synthesizes great moments in history, the current state of the science, and future directions of drug discovery into one expertly written and organized work. Exploring all major therapeutic areas, the book introduces readers to all facets and phases of drug discovery, including target selection, biological testing, drug metabolism, and computer-assisted drug design.Drug Discovery features chapters written by an international team of pharmaceutical and medicinal chemists. Contributions are based on a thorough review of the current literature as well as the authors' firsthand laboratory experience in drug discovery. The book begins with the history of drug discovery, describing groundbreaking moments in the field. Next, it covers such topics as: Target identification and validationDrug metabolism and pharmacokineticsCentral nervous system drugsIn vitro and in vivo assaysCardiovascular drugsCancer drugsEach chapter features a case study, helping readers understand how science is put into practice throughout all phases of drug discovery. References at the end of each chapter serve as a gateway to groundbreaking original research studies and reviews in the field.Drug Discovery is ideal for newcomers to medicinal chemistry and drug discovery, providing a comprehensive overview of the field. Veterans in the field will also benefit from the perspectives of leading international experts in all aspects of drug discovery.

    Produktinformation

    • Utgivningsdatum:2013-04-26
    • Mått:185 x 259 x 34 mm
    • Vikt:1 148 g
    • Format:Inbunden
    • Språk:Engelska
    • Antal sidor:570
    • Förlag:John Wiley & Sons Inc
    • ISBN:9780470942352

    Utforska kategorier

    • Farmakologi inom Medicin
    • Tillverkningsteknik inom Naturvetenskap och teknik

    Mer om författaren

    JIE JACK LI, PhD, is a chemist at Bristol-Myers Squibb Company. He has authored or edited several books published by Wiley, including Name Reactions in Heterocyclic Chemistry, Name Reactions for Functional Group Transformations, Name Reactions for Homologations (Part I and Part II), Name Reactions for Carbocyclic Ring Formations, Contemporary Drug Synthesis, The Art of Drug Synthesis, and Modern Drug Synthesis.E. J. COREY, PhD, has been a Professor at Harvard University since 1959. The 1990 Nobel Laureate in Chemistry, Dr. Corey has also been the recipient of more than seventy international awards and honorary degrees, including the U.S. National Medal of Science, the Japan Prize in Science, and the Priestley Medal. Author of more than 1,500 publications, he is one of the most cited authors in science.

    Recensioner i media

    “Taken together, the book is an excellent introduction into drug discovery and an eminent summary of the very important milestones of drug discovery in the most critical indication areas. This book is a valuable addition to the library of all different kinds of scientists working in the field of drug discovery.”  (ChemMedChem, 1 October 2013)

    Innehållsförteckning

    • Chapter 1. History of Drug Discovery 11. Introduction 12. Antibacterials 13. Cancer Drugs 64. Cardiovascular Drugs 105. Cholesterol Drugs 166. CNS Drugs 217. Anti-inflammatory Drugs 268. Anti-ulcer Drugs 309. Antiviral Drugs 3310. References 38Chapter 2. Target Identification and Validation 431. History 432. Definition of Drug Targets 433. Classification of Currently Utilized Drug Targets 454. Receptors as Drug Targets 465. Enzymes as Drug Targets 486. Transporter Proteins as Drug Targets 497. Modern Technologies Employed in Target Identification and Validation 498. Impact of Therapeutic Modalities on the Selection Drug Targets 629. Future Directions 6310. References3. In vitro and in vivo Assays 671. Introduction 672. The Testing Funnel 673. In vitro assays 704. In vivo Assays 895. Outlook 926. References 93Chapter 4. Drug Metabolism and Pharmacokinetics in Drug Discovery 951. Introduction 952. Drug Metabolism 973. Pharmacokinetic Fundamentals 1064. Drug Metabolism and Pharmacokinetics in Drug Discovery 951. Introduction 952. Drug Metabolism 973. Pharmacokinetic Fundamentals 1064. Pharmacokinetics Studies in Support of Drug Optimization 1125. Absorption and Permeability 1146. Drug Transporters 1177. Protein Binding 1198. Pharmacokinetics and Pharmacodynamics 1239. Predicting Human Pharmacokinetics 13010. Summary 13311. References 133Chapter 5. Cardiovascular Drugs 1371. Introduction 1372. Early History of Coronary Heart Disease (CHD) 1383. Lipid Lowering Agents 1394. Antihypertensive Agents 1535. Antithrombotic Drugs 1776. Thrombolytic Agents 1907. Anti-anginal Agents 1918. Heart Failure Drugs 1919. The Future 19310. References 193Chapter 6. Diabetes Drugs 2011. Introduction 2012. Current therapies for Type 2 Diabetes 2043. Other Treatments for T2DM 2154. Novel Mechanisms of Action: Future Treatments for Type 2 Diabetes 2175. Current Therapies for Type 1 Diabetes 2216. Future Treatments for Type 1 Diabetes 2277. Future Prospects for New Diabetes Drugs 2318. References 231Chapter 7. CNS Drugs 2411. Introduction 2412. Antipsychotic Drugs 2413. Antidepressant drugs 2464. Drugs for Epilepsy and Bipolar Disorder 2555. Anxiolytic Drugs 2596. Centrally Acting Analgesic Drugs 2627. Drugs for treating Substance Abuse and ADHD 2658. Drugs for Neurodegenerative Diseases 2679. Future Prospects for New CNS Drugs 27310. References 276Chapter 8. Cancer Drugs 2831. Introduction 2832. Historical Perspective of Cancer Drugs 2853. Antimetabolites 2864. Alkylating Agents 2915. Platinum Complexes 2946. Plant and Marine Based Natural Products 2957. Toposiomerase Inhibitors 3008. Antitumor Antibiotics 3059. Tyrosine Kinase Inhibitors (TKI) 30610. Hormones 31411. Histone Deacylase (HDAC) Inhibitors 32112. Miscellaneous Cancer Drugs 32313. Conclusion 32514. References 326Chapter 9. Antiinflammatory and Immunomodulatory Drugs 3331. Introduction 3332. Arachidonic Acid Cascade 3343. Leukotriene Pathway Inhibitors 3474. Anti-histamines 3515. Corticosteroids 3536. Rheumatoid Arthritis 3567. Osteoarthritis 3638. Chronic Inflammatory Arthritis and Gout 3649. Multiple Sclerosis 36610. Transplantation 36811. Biological Agents That Suppress Cytokine Production or Signaling 37212. B Cell Therapy 37413. Cytotoxic T-lymphocyte Antigen 4 (CTLA4) 37414. Interleukins 37515. Safety 37716. Summary 37717. References 378Chapter 10. Anti-bacterial Drugs 3851. Introduction 3852. The Rise and Decline of Antibiotics 3863. The Unique Challenges of Anti-bacterial Drug Discovery 3874. Antibiotic Classes 3905. Emerging Strategies to Discover New Anti-bacterial Drugs 4206. Conclusions 4257. References 425Chapter 11. Antiviral Drug Discovery 4371. Introduction 4372. Human Immunodeficiency Virus-1 Inhibitors 4423. Hepatitis B Virus Inhibitors 4594. Hepatitis C Virus Inhibitors 4635. Inhibitors of Respiratory Viruses-Influenza and Respiratory Syncytial Virus 4766. Herpesviridae Inhibitors 4877. Epilogue 4908. References 490Index 517